Zhejiang Canaan Technology Limited (300412) Fair Value & Analysis
Industrials · CN · Market cap 2.1B CNY
Fair value as of: Jun 24, 2026
Analysis
Zhejiang Canaan Technology Limited (300412) currently trades at ¥4.19, while our model-based Fair Value estimate is ¥1.51 — implying the stock looks roughly 64.0% overvalued today. We read business quality at 93/100 (high quality), in the Industrials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).
About the company
Zhejiang Canaan Technology Limited engages in the research and development, production, and sale of pharmaceutical equipment in China and internationally. The company offers preprocessing module, hybrid module, packaging, attachment, granulation, material transport, cleaning, continuous manufacturing, container, freeze drying system, and fluid module products. It also provides EPCMV turnkey, solid dosage, API system, pharmaceutical water, smart packaging, intelligent warehousing and automated logistics, pharmaceutical research and development integrated services, and pharmaceutical digital solutions. It primarily serves pharmaceutical industry. The company was founded in 2000 and is based in Wenzhou, China.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Zhejiang Canaan Technology Limited (300412) undervalued?
What is the fair value of 300412?
What is the quality score of 300412?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.